Biotech

As gene-based therapies move from lab to clinic, how can business and government bridge the gap between availability and access?

The FDA is reviewing evidence from hundreds of people that used the company’s watch

Nerve-stimulating therapies could soon replace drugs for many chronic conditions

A new generation of tools could help end one-size-fits-all therapeutics

A genetic tool that can alter—and potentially eliminate—entire species has taken a dramatic leap forward

Machine-learning algorithms are speeding up the search for novel drugs and materials

Releasing drugs directly into patients’ bodies as they are needed is fast becoming feasible

Scientists scoured variants of BRCA1 to determine which are pathogenic

Interview: Joan Argetsinger Steitz weighs in on #MeToo and working with James Watson

With new gene-editing techniques, the controversial technology will no longer be necessary

Up to 10,000 bugs could be deployed

This outdated, expensive tech is getting a big makeover